{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T09:49:49Z","timestamp":1725875389922},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.diagmicrobio.2024.116253","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T16:18:05Z","timestamp":1710605885000},"page":"116253","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety of an inactivated COVID-19 vaccine (CoronaVac) in children aged 7-14 years in Taizhou, China"],"prefix":"10.1016","volume":"109","author":[{"given":"Dong-sheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-ping","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-xue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0001","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2471\/BLT.20.255778","article-title":"COVID-19 control strategies in Taizhou city","volume":"98","author":"Lin","year":"2020","journal-title":"China. Bull World Health Organ."},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Micro"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0003","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/INF.0000000000002660","article-title":"Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children","volume":"39","author":"Zimmermann","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MOP.0000000000000978","article-title":"COVID-19 vaccine development: a pediatric perspective","volume":"33","author":"Kamidani","year":"2021","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0005","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0006","doi-asserted-by":"crossref","first-page":"252","DOI":"10.7326\/M20-8008","article-title":"COVID-19 vaccine: promoting vaccine acceptance","volume":"174","author":"Laine","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0007","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0008","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1016\/j.vaccine.2015.04.040","article-title":"Strategies for addressing vaccinehesitancy - A systematic review","volume":"33","author":"Jarrett","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0009","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/vaccines9030191","article-title":"The changing acceptance of COVID-19 vaccination in different epidemic phases in china: a longitudinal study","volume":"9","author":"Wang","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/14760584.2021.1925112","article-title":"Safety of an inactivated SARS-COV-2 vaccine among healthcare workers in China","volume":"20","author":"Zhang","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0011","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/healthcare9101353","article-title":"Exploring and monitoring the reasons for hesitation with COVID-19 vaccine based on social-platform text and classification algorithms","volume":"9","author":"Liu","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.705882","article-title":"Roles of children and adolescents in COVID-19 transmission in the community: a retrospective analysis of nationwidedata in Japan","volume":"9","author":"Imamura","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0013","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ajcp\/aqaa272","article-title":"Herd immunity to COVID-19","volume":"155","author":"Kadkhoda","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116253_bib0014","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2049169","article-title":"Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China","volume":"18","author":"Ma","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0016","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s10900-022-01112-5","article-title":"A Cross-sectional study of untoward reactions following homologous and heterologous COVID-19 booster immunizations in recipients seventeen years of age and older","volume":"47","author":"Tamburro","year":"2022","journal-title":"J Community Health"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0017","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1080\/21645515.2020.1834325","article-title":"Factors associated with parents\u2019 willingness to enroll their children in trials for COVID-19 vaccination","volume":"17","author":"Goldman","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116253_bib0018","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/vaccines10101765","article-title":"Safety after BBIBP-CorV (Sinopharm) COVID-19 vaccine in adolescents Aged 10-17 years in Thailand","volume":"10","author":"Thonginnetra","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0019","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1590\/s1678-9946202163083","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in inadvertently vaccinated healthy children","volume":"63","author":"Fernandes","year":"2021","journal-title":"Rev Inst MedTrop Sao Paulo"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0020","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2126668","article-title":"Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Results from an active pharmacovigilance study in central Italy","volume":"18","author":"Ripabelli","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0021","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"3","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0024","doi-asserted-by":"crossref","first-page":"2082207","DOI":"10.1080\/21645515.2022.2082207","article-title":"COVID-19 vaccine counseling and safety assessment in children and teenagers with underlying medical conditions in China: a single center study","volume":"18","author":"Zeng","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0025","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1159\/000524099","article-title":"CoronaVac\/Sinovac COVID-19 vaccine-related hypersensitivity reactions and second-dose vaccine administration: tertiary allergy center experience","volume":"183","author":"Gumusburun","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0026","doi-asserted-by":"crossref","first-page":"2096970","DOI":"10.1080\/21645515.2022.2096970","article-title":"CoronaVac: a review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2","volume":"18","author":"Jin","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0027","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0028","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/clinpract11040093","article-title":"Analysis of the delta variant B.1.617.2 COVID-19","volume":"11","author":"Shiehzadegan","year":"2021","journal-title":"Clin Pract"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0029","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/vaccines10020160","article-title":"Antibody response of combination of BNT162b2 and coronavac platforms of COVID-19 vaccines against omicron variant","volume":"10","author":"Khong","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116253_bib0031","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324000828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324000828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T09:07:30Z","timestamp":1714208850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0732889324000828"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116253","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of an inactivated COVID-19 vaccine (CoronaVac) in children aged 7-14 years in Taizhou, China","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116253"}}